Official announcements
messages in brief
|
06/11/2023
#MedSafetyWeek from November 6 to 12, 2023 - Reporting suspected adverse drug reactions helps to improve the safety of medicines. In a joint "MedSafetyWeek" campaign, pharmaceutical authorities around the world are reminding people how important it is to report suspected cases of adverse drug reactions. This year's campaign focuses on the important role of healthcare professionals and patients, who contribute to the safety of medicines by reporting suspected side effects.
messages in brief
|
31/10/2023
This issue of RMS NEWS again contains current and relevant news for our applicants for marketing authorisations with Austria as RMS.
CHMP Monthly News
|
30/10/2023
Up-to-date information from the June 09.10.-12.10.2023 meeting on new approvals, extensions of indication, newly published EPAR's and recently started procedures.
messages in brief
|
20/10/2023
CHESSMEN Board meets in Rome to discuss shortage prevention.
Safety warnings
|
messages in brief
|
12/10/2023
BASG informs about current developments and necessary measures in case of counterfeiting of the medicinal product Ozempic® in German presentation.
CHMP Monthly News
|
26/09/2023
Up-to-date information from the June 11.09.-14.09.2023 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.
Recall
|
Medicines
|
15/09/2023
Recall due to nitrosamine contamination above the permitted daily dose
Recall
|
Medicines
|
01/09/2023
Recall due to increased release of active ingredient
Recall
|
Medicines
|
21/08/2023
Recall due to contamination with salbutamol
messages in brief
|
21/08/2023
On Friday 18.8.2023 a delegation of the Chinese Drug Administration Zhejiang Medical Products Administration visited the AGES Medical Market Surveillance for an exchange and deeper insights into the fields of activity.